CD44 and HCELL: preventing hematogenous metastasis at step 1.
CD44 and HCELL: preventing hematogenous metastasis at step 1.
复制标题
DOI:
10.1016/j.febslet.2011.07.039
复制
发表时间:
2011-10-20
期刊:
影响因子:
3.5
通讯作者:
Sackstein R
中科院分区:
文献类型:
--
作者:
Jacobs PP;Sackstein R
Despite great strides in our knowledge of the genetic and epigenetic changes underlying malignancy, we have limited information on the molecular basis of metastasis. Over 90% of cancer deaths are caused by spread of tumor cells from a primary site to distant organs and tissues, highlighting the pressing need to define the molecular effectors of cancer metastasis. Mounting evidence suggests that circulating tumor cells home to specific tissues by hijacking the normal leukocyte trafficking mechanisms. Cancer cells characteristically express CD44, and there is increasing evidence that HCELL, a sialofucosylated glycoform of CD44, serves as the major selectin ligand on cancer cells, allowing interaction of tumor cells with endothelium, leukocytes, and platelets. Here, we review the structural biology of CD44 and of HCELL, and present current data on the function of these molecules in mediating organ-specific homing/metastasis of circulating tumor cells.
登录
查看更多内容
DOI:
10.1084/jem.180.1.53
发表时间:
1994-07-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Bartolazzi A;Peach R;Aruffo A;Stamenkovic I
通讯作者:
Stamenkovic I
DOI:
10.1083/jcb.131.6.1623
发表时间:
1995-12
期刊:
The Journal of cell biology
影响因子:
--
作者:
Bennett KL;Modrell B;Greenfield B;Bartolazzi A;Stamenkovic I;Peach R;Jackson DG;Spring F;Aruffo A
通讯作者:
Aruffo A
影响因子:
8
作者:
Arnott, CH;Scott, KA;Balkwill, FR
通讯作者:
Balkwill, FR
DOI:
10.1073/pnas.0703478104
发表时间:
2007-06-12
影响因子:
11.1
作者:
Dalerba, Piero;Dylla, Scott J.;Clarke, Michael F.
通讯作者:
Clarke, Michael F.
DOI:
10.1006/bbrc.1996.1475
发表时间:
1996-10-03
影响因子:
3.1
作者:
Dasgupta, A;Takahashi, K;Tanabe, KK
通讯作者:
Tanabe, KK